Glyco-poly-L-lysine is better than liposomal delivery of exogenous genes to rat liver

World Journal of Gastroenterology

Volumn 6, Issue 4, 2000, Pages 526-531

  Yang, C Q ^a   Wang, J Y ^a   He, B M ^a   Liu, J J ^a   Guo, J S ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOFECTAMINE; LIPOSOME; PLASMID DNA; POLYLYSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFECT; DRUG POTENCY; DRUG UPTAKE; EUKARYOTIC CELL; GENE EXPRESSION; GENE THERAPY; IN SITU HYBRIDIZATION; IN VIVO STUDY; LIVER DISEASE; MALE; NONHUMAN; RAT;

EID: 0033843310     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Human gene therapy comes of age
2. Human gene therapy
3. Construction of retroviral vectors to induce a strong expression of human class I interferon gene in human hepatocellular carcinoma cells in vitro
4. In vivo gene therapy: A strategy to use human gene as therapeutics
5. Current status of gene therapy in gastroenterology
6. Gene transfer technologies for the gene therapy of cancer
7. Gene therapy for human colorectal carcinoma using promoter controlled bacterial ADP-ribosylating toxin genes human CEA: PEA and DTA gene transfer
8. Retrovirus mediated antisense RNA to bcl 2 alter the biological behavior of stomach carcinoma MGC 803 cell lines
9. Antisense to cyclin D1 reverses the transformed phenotype of human gastric cancer cells
10. Delivery systems for gene therapy
11. The Hsp90 chaperone complex-A potential target for cancer therapy?
12. Study on liver targeting and hepatocytes permeable valaciclovir polybutylcyanoacrylate nanoparticles
13. Targeting chemical therapy: New focus of gene therapy
14. Gene therapy of the liver: From the laboratory to the patient's bedside
15. Gene therapy for human liver diseases
16. CEA and AFP expression in human hepatoma cells transfected with antisense IGF I gene
17. Potentiation of cationic liposome-mediated gene delivery by polycations
18. Antisense to cyclin D1 reverses the transformed phenotype of human gastric cancer cells
19. Expression of hepatitis B virus surface antigen in adult rat liver: Cointroduction of DNA and nuclear protein by a simplified liposome method
20. Receptor-mediated gene delivery in vivo: Partial correction of genetic analbuminemia in Nagase rats
21. Receptor-mediated gene delivery and expression in vivo
22. A DNA delivering system containing listeriolysin O results in enhanced hepatocyte-directed gene expression
23. Gene transfer in primary cultures of human hepatocytes
24. In vivo disposition characteristics of plasmid DNA complexed with cationic liposomes
25. Gene expression and active virus replication in the liver after injection of duck hepatitis B virus DNA into the peripheral vein of ducklings
26. Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: Implication in drug delivery
27. Overexpression of human methylmalonyl CoA mutase in mice after in vivo gene transfer with asialoglycoprotein/polylysine/DNA complexes
28. Nonenzymatic glycosylation of poly-L-lysine: A new tool for targeted gene delivery
29. Specific delivery to liver cells by asialoglycoprotein modified antisense oligodeoxynucleotides in vitro and in vivo
30. Galactose-specific receptor modulation related to the onset of apoptosis in rat liver
31. Rat collagenase
32. The constrution of mammalian expression plasmid of Flag-tagged rat collagenase and its transfection study in vitro
33. A comparison between intravenous and peritoneal route on liver targeted uptake and expression of plasmid delivered by Glyco-poly-L-lysine
34. In situ hybridization of tissues and cells
35. In situ hybridization and immunohistochemistry
36. The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family
37. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate
38. In vivo fate of phosphorothioate antisense oligodeoxynucleotides: Predominant uptake by scavenger receptors on endothelial liver cells
39. Sequencing of PCR amplified HBV DNA pre c and c regions in the 2-2-15 cells and antiviral action by targeted antisense oligonucleotide directed against the sequence
40. Study on liver targeting and hepatocytes permeable valaciclovir polybutylcyan-oacrylate nanoparticles
41. The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus
42. Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis
43. Fate of DNA targeted to the liver by asialoglycoprotein receptor-mediated endocytosis in vivo. Prolonged persistence in cytoplasmic vesicles after partial hepatectomy
44. Asialoglycoprotein receptor mRNAs are expressed in most extrahepatic rat tissues during development
45. Detexction of asialoglycoprotein receptor on cell lines of extrahepatic origin
46. Liposome mediated gene transfer
47. Liposomes as carrier for antibiotics: A comparative study on the immune response against liposome-encapsulated penicillin and other penicillin preparations
48. Efficient gene transduction by Epstein-Barr-virus-based vectors coupled with cationic liposome and HVJ-liposome
49. Inhibitory effects of EGFG antisense oligodeoxy-nucleotide with liposome in human colorectal cancer cell line
50. In vitro liposome-mediated DNA transfection of epithelial cell lines using the cationic liposome DC-Chol/DOPE
51. Liposomes as carriers of DNA
52. Biologically active, recombinant DNA in clathrin-coated vesicles isolated from rat livers after in vivo injection of liposome-encapsulated DNA